Reply to F.-C. Bidard et al

Affiliations

¹ University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
² SWOG Statistical Center, Seattle, WA.
³ University of Texas MD Anderson Cancer Center, Houston, TX.
⁴ University of Michigan Comprehensive Cancer Center, Ann Arbor, MI hayesdf@umich.edu.

Comment

Jeffrey B Smerage et al. J Clin Oncol. 2015.

. 2015 May 10;33(14):1623.

doi: 10.1200/JCO.2014.60.5519. Epub 2015 Apr 13.

¹ University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
² SWOG Statistical Center, Seattle, WA.
³ University of Texas MD Anderson Cancer Center, Houston, TX.
⁴ University of Michigan Comprehensive Cancer Center, Ann Arbor, MI hayesdf@umich.edu.

No abstract available

Comment on

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.
Smerage JB, Barlow WE, Hortobagyi GN, Winer EP, Leyland-Jones B, Srkalovic G, Tejwani S, Schott AF, O'Rourke MA, Lew DL, Doyle GV, Gralow JR, Livingston RB, Hayes DF. Smerage JB, et al. J Clin Oncol. 2014 Nov 1;32(31):3483-9. doi: 10.1200/JCO.2014.56.2561. Epub 2014 Jun 2. J Clin Oncol. 2014. PMID: 24888818 Free PMC article. Clinical Trial.
Clinical utility of circulating tumor cells in metastatic breast cancer.
Bidard FC, Pierga JY. Bidard FC, et al. J Clin Oncol. 2015 May 10;33(14):1622. doi: 10.1200/JCO.2014.57.9714. Epub 2015 Apr 13. J Clin Oncol. 2015. PMID: 25870091 No abstract available.